Metastatic triple-negative breast cancer successfully treated with bicalutamide

Triple-negative breast cancer (TNBC) is considered the group with the worst prognosis among the four molecular subtypes of breast cancer. The current treatment of metastatic TNBC is traditionally limited to chemotherapy. Androgenic receptors (AR) are an emerging target with therapeutic potential in...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar Mejía, Carlos Eduardo, García Gutierrez, María Elena, Rodríguez Alvarez, Carlos Javier, Flores Caballero, Miguel Angel, Wimer Castillo, Blanca Otilia, Vidal Gutiérrez, Oscar
Formato: Artículo
Lenguaje:inglés
Publicado: African Field Epidemiology Network 2020
Acceso en línea:http://eprints.uanl.mx/29984/7/29984.pdf

Ejemplares similares